Verilogue

Verilogue specializes in capturing and analyzing real-world physician-patient conversations to provide pharmaceutical and healthcare brands with authentic market insights. Founded in 2005 by Jeff Kozloff and Jamison Barnett, the company maintains the world's largest collection of in-office physician-patient interactions, comprising over 250,000 conversations totaling more than 2 million audio minutes across 20 physician specialties, 70 therapeutic areas, and 120 disease states.

The company's methodology moves beyond traditional recall-based research by analyzing actual exam room dialogue to understand patient experiences, treatment barriers, and healthcare provider communication patterns. Their proprietary Reveal platform combines linguist-trained artificial intelligence with qualitative data management to help pharmaceutical brand teams uncover actionable insights from point-of-care interactions.

As part of Publicis Groupe since their acquisition, Verilogue works closely with Digitas Health to integrate conversation analytics into omnichannel pharmaceutical marketing strategies. The company serves a global client base with expertise spanning patient adherence research, treatment pathway analysis, and brand positioning insights derived from authentic clinical conversations.

Choose Verilogue when your pharmaceutical brand needs to understand the authentic dynamics of clinical decision-making and patient communication that traditional research methods cannot capture. Their extensive conversation database and linguistic analysis expertise excel at uncovering treatment barriers, adherence challenges, and messaging opportunities that emerge in real exam room interactions.

Expect a research partner that combines qualitative depth with technological scale, particularly valuable for brand teams developing patient support strategies, refining messaging, or seeking to understand competitive positioning from the physician and patient perspective during actual clinical encounters.

Verilogue serves exclusively within the pharmaceutical and life sciences sectors, providing specialized insights for drug manufacturers and healthcare brands. Their healthcare expertise encompasses 70 therapeutic areas and 120 disease states, with particular depth in understanding treatment adherence challenges, patient-physician communication patterns, and clinical decision-making dynamics specific to pharmaceutical brand strategy and market access.

As part of Publicis Groupe's healthcare division, the company integrates point-of-care insights with pharmaceutical marketing execution through their partnership with Digitas Health, focusing specifically on the unique regulatory and commercial needs of life sciences organizations.

Pharmaceutical manufacturers and biotech companies launching new therapies or seeking to improve adherence and market positioning for existing brands. Organizations that value authentic patient insights and want to understand the nuanced communication dynamics between healthcare providers and patients in real clinical settings rather than controlled research environments.